The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2022
Filed:
Jun. 26, 2020
Applicant:
Exocobio Inc., Seoul, KR;
Inventors:
Assignee:
ExoCoBio Inc., Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/98 (2006.01); A61K 8/04 (2006.01); A61K 8/73 (2006.01); A61K 8/92 (2006.01); A61K 9/19 (2006.01); A61K 35/28 (2015.01); A61Q 19/00 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 8/981 (2013.01); A61K 8/044 (2013.01); A61K 8/735 (2013.01); A61K 8/925 (2013.01); A61K 9/19 (2013.01); A61K 35/28 (2013.01); A61Q 19/00 (2013.01); A61K 9/0019 (2013.01); A61K 2800/70 (2013.01); A61K 2800/74 (2013.01); A61K 2800/84 (2013.01); A61K 2800/86 (2013.01); A61K 2800/91 (2013.01);
Abstract
The lyophilized formulation of stem cell-derived exosomes and the anti-inflammatory composition including the same as an active ingredient is able to stabilize stem cell-derived exosomes and exhibit excellent anti-inflammatory effects, and particularly, exhibit remarkable anti-inflammatory effects as compared with not-lyophilized stem cell-derived exosomes isolated and purified from conditioned media of stem cells. Therefore, the lyophilized formulation of stem cell-derived exosomes and the anti-inflammatory composition including the same as an active ingredient is able to effectively prevent, suppress, alleviate, ameliorate or treat inflammatory response or inflammatory diseases.